Astrazeneca Plc Balance Sheet Annual
AZN
|
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
|
AZN Balance Sheets
(Annual, GAAP in millions $) |
(Dec 31 2023)
2023 |
(Dec 31 2022)
2022 |
(Dec 31 2021)
2021 |
(Dec 31 2020)
2020 |
(Dec 31 2017)
2017 |
|
ASSETS |
| Cash & cash equivalent |
- |
- |
- |
- |
- |
| Cash And Cash Equivalents |
5,840.00 |
6,166.00 |
6,329.00 |
7,832.00 |
- |
| Cash
& Short-term Investments |
5,840.00 |
6,166.00 |
6,329.00 |
7,832.00 |
- |
| Accounts receivable |
- |
- |
- |
- |
- |
| Other Receivables |
- |
- |
- |
- |
- |
| Inventories |
5,424.00 |
4,699.00 |
8,983.00 |
4,024.00 |
- |
| Inventories |
- |
- |
- |
- |
- |
| Other Current Assets |
13,790.00 |
11,728.00 |
10,932.00 |
7,688.00 |
- |
| Total Current Assets |
25,054.00 |
22,593.00 |
26,244.00 |
19,544.00 |
- |
| Equipment/Property/Plant Net |
9,402.00 |
8,507.00 |
9,183.00 |
8,251.00 |
- |
| Goodwill net |
20,048.00 |
19,820.00 |
19,997.00 |
11,845.00 |
11,825.00 |
| Intangible Assets |
- |
- |
- |
- |
- |
| Long-term investments |
- |
- |
- |
- |
- |
| Accounts Receivable, Net, Noncurrent |
- |
- |
- |
- |
- |
| Financial Instruments |
- |
- |
- |
- |
- |
| Deferred Tax Assets |
4,718.00 |
3,263.00 |
4,330.00 |
3,438.00 |
- |
| Other Assets, Noncurrent |
41,897.00 |
42,300.00 |
45,609.00 |
23,651.00 |
51,529.00 |
| Deferred, Prepaid and Other Assets, Noncurrent |
- |
- |
- |
- |
- |
| Discontinued operations, Noncurrent |
- |
- |
- |
- |
- |
| Noncurrent Assets |
76,065.00 |
73,890.00 |
79,119.00 |
47,185.00 |
- |
| Total Assets |
101,119.00 |
96,483.00 |
105,363.00 |
66,729.00 |
63,354.00 |
| LIABILITIES |
| Accounts Payable |
- |
- |
- |
- |
- |
| Accrued Liabilities, Current |
- |
- |
- |
- |
- |
| Current Tax Liabilities |
-1,584.00 |
-896.00 |
-916.00 |
-1,127.00 |
- |
| Longterm Borrowings |
-22,365.00 |
-22,965.00 |
-28,134.00 |
-17,505.00 |
- |
| Other Liabilities, Current |
- |
- |
7,224.00 |
- |
- |
| Taxes Payable |
- |
- |
- |
- |
- |
| Current Provisions |
-1,028.00 |
-722.00 |
-768.00 |
-976.00 |
- |
| Discontinued Operation, Liabilities, Current |
- |
- |
- |
- |
- |
| Total Current Liabilities |
-24,977.00 |
-24,583.00 |
-22,594.00 |
-19,608.00 |
- |
| Long-term debt |
- |
- |
- |
- |
- |
| Capital Lease and Other |
- |
- |
- |
- |
- |
| Long-term Debt Convertible |
- |
- |
- |
- |
- |
| Total
Long-term Debt |
- |
- |
- |
- |
- |
| Financial Instruments, Insurance, Noncurrent |
- |
- |
- |
- |
- |
| Employee Benefit Plans, Noncurrent |
- |
- |
- |
- |
- |
| Deferred credits, Noncurrent |
- |
- |
- |
- |
- |
| Deferred Tax Liabilities, Net LI |
-2,844.00 |
-2,944.00 |
-6,206.00 |
-2,918.00 |
-3,995.00 |
| Discontinued Operation, Liabilities, Noncurrent |
- |
- |
- |
- |
- |
| Noncurrent Provisions |
- |
- |
- |
- |
- |
| |
-1,520.00 |
-1,168.00 |
-2,454.00 |
-3,202.00 |
- |
| Total Liabilities |
-27,821.00 |
-27,527.00 |
-28,800.00 |
-22,526.00 |
-3,995.00 |
SHAREHOLDER'S EQUITY |
| Other Equity |
39,160.00 |
37,053.00 |
39,284.00 |
15,690.00 |
110,066.00 |
| Noncontrolling interests & other |
- |
- |
- |
- |
- |
| Total
Stockholder's Equity |
39,166.00 |
37,058.00 |
39,287.00 |
15,638.00 |
110,066.00 |
| Liabilities & Stockholder's
Equity |
11,345.00 |
9,531.00 |
105,363.00 |
66,729.00 |
63,354.00 |
|
|
